Primary results from the phase 2 randomized, placebo controlled, blinded trial of the monoclonal antibody coramitug in transthyretin amyloid cardiomyopathy (ATTR-CM)
Authors:
Marianna Fontana1; Pablo Garcia-Pavia2; Martha Grogan3; Sanjiv J Shah4; Mads D M Engelmann5; G Kees Hovingh5; Arnt V Kristen6; Michelle Lim-Watson7; Brian Malling7; Soumitra Kar8; Manjunatha Revanna5; Nitasha Sarswat9; Kenichi Tsujita10 Mathew S Maurer11